Matches in Wikidata for { <http://www.wikidata.org/entity/Q66389054> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q66389054 description "clinical trial" @default.
- Q66389054 description "ensayu clínicu" @default.
- Q66389054 description "klinisch onderzoek" @default.
- Q66389054 description "клінічне випробування" @default.
- Q66389054 name "Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas" @default.
- Q66389054 name "Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas" @default.
- Q66389054 type Item @default.
- Q66389054 label "Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas" @default.
- Q66389054 label "Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas" @default.
- Q66389054 prefLabel "Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas" @default.
- Q66389054 prefLabel "Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas" @default.
- Q66389054 P1050 Q66389054-7C33F4C3-08DA-4521-86EE-8D84E5771B9A @default.
- Q66389054 P1132 Q66389054-B4E11499-C326-47C2-8417-C7599E22C2A4 @default.
- Q66389054 P1476 Q66389054-1E9C4F12-2B2F-40BD-836B-2D9CDC61E2BD @default.
- Q66389054 P2899 Q66389054-6F55E9ED-DCF8-4FE9-B60A-2738027416A5 @default.
- Q66389054 P3098 Q66389054-32504CEC-2310-4793-92F7-D62BCF028EC0 @default.
- Q66389054 P31 Q66389054-E4354B17-4047-4476-A43C-9D831A2D5CD5 @default.
- Q66389054 P4135 Q66389054-95CA6E44-3822-45F9-B1DD-92ADBBE49F80 @default.
- Q66389054 P4844 Q66389054-6AB1956A-1449-4B01-AE2C-676F8C8984C8 @default.
- Q66389054 P4844 Q66389054-7E1DC92A-86CB-47CA-94CA-8CADB0A676F4 @default.
- Q66389054 P580 Q66389054-E896E933-0CB0-4230-B494-975074DA0F98 @default.
- Q66389054 P582 Q66389054-4C9B7A02-E127-4521-B4F8-38234EB937F8 @default.
- Q66389054 P6099 Q66389054-8508FB5B-FE2B-486B-A2DF-0CAA2C6708F7 @default.
- Q66389054 P8363 Q66389054-C94B7378-70DB-45C8-90A6-D6C46DFF7316 @default.
- Q66389054 P1050 Q223911 @default.
- Q66389054 P1132 "+28" @default.
- Q66389054 P1476 "An Open-Label, Phase II Efficacy Trial of Doxorubicin in Combination With Dual Checkpoint Blockade Using AGEN1884 and AGEN2034 for Advanced or Metastatic Soft Tissue Sarcomas" @default.
- Q66389054 P2899 "+18" @default.
- Q66389054 P3098 "NCT04028063" @default.
- Q66389054 P31 Q30612 @default.
- Q66389054 P4135 "+100" @default.
- Q66389054 P4844 Q18936 @default.
- Q66389054 P4844 Q29004943 @default.
- Q66389054 P580 "2019-08-01T00:00:00Z" @default.
- Q66389054 P582 "2021-11-24T00:00:00Z" @default.
- Q66389054 P6099 Q42824440 @default.
- Q66389054 P8363 Q78089383 @default.